Published in J Neural Transm (Vienna) on January 01, 1999
Astrocytes in Alzheimer's disease. Neurotherapeutics (2010) 1.47
Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis Assoc Disord (2007) 1.29
Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxid Redox Signal (2012) 1.24
Why pleiotropic interventions are needed for Alzheimer's disease. Mol Neurobiol (2010) 1.18
Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. Antioxid Redox Signal (2010) 1.04
4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies. Antioxid Redox Signal (2012) 1.01
Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS One (2011) 0.94
Non-chaperone proteins can inhibit aggregation and cytotoxicity of Alzheimer amyloid β peptide. J Biol Chem (2014) 0.87
Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease. J Alzheimers Dis (2010) 0.86
Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology? Aging Neurodegener (2013) 0.86
Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane. PLoS One (2011) 0.82
Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology. Proteome Sci (2010) 0.81
Glaucoma related Proteomic Alterations in Human Retina Samples. Sci Rep (2016) 0.81
Translational potential of astrocytes in brain disorders. Prog Neurobiol (2015) 0.80
Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity. J Biol Chem (2015) 0.80
Reevaluating Metabolism in Alzheimer's Disease from the Perspective of the Astrocyte-Neuron Lactate Shuttle Model. J Neurodegener Dis (2013) 0.79
Alois Alzheimer revisited: differences in origin of the disease carrying his name. J Neural Transm (Vienna) (2006) 0.79
Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma. PLoS One (2015) 0.78
Ethyl Pyruvate Emerges as a Safe and Fast Acting Agent against Trypanosoma brucei by Targeting Pyruvate Kinase Activity. PLoS One (2015) 0.78
Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs. Mol Neurobiol (2016) 0.78
Ethyl Pyruvate Combats Human Leukemia Cells but Spares Normal Blood Cells. PLoS One (2016) 0.76
Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions. Acta Neuropathol Commun (2015) 0.75
Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease. J Cell Mol Med (2012) 0.75
Astrocyte and Alzheimer's disease. J Neurol (2017) 0.75
Rapid identification of viridans streptococci by mass spectrometric discrimination. J Clin Microbiol (2007) 2.49
Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol (1983) 1.91
Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci (1997) 1.73
Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience (1985) 1.59
Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis. Brain Res Bull (1982) 1.51
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.50
Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly. Neurobiol Aging (2001) 1.27
Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int (1997) 1.21
Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology. J Neurosci Res (2001) 1.20
Quantification of bacteria in oral samples by competitive polymerase chain reaction. J Dent Res (1999) 1.15
Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease. Neuroscience (1999) 1.11
Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms. Neurochem Int (1992) 1.10
Differentiation of mutans streptococci by intact cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Oral Microbiol Immunol (2005) 1.09
Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration. J Cell Biol (2000) 1.08
Chondroitin sulfate proteoglycan-immunoreactivity of lectin-labeled perineuronal nets around parvalbumin-containing neurons. Brain Res (1994) 1.06
Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders. Brain Res Mol Brain Res (1999) 1.04
Pseudophosphorylation of tau protein alters its ability for self-aggregation. J Neurochem (2004) 1.03
Substitution of Arg214 at the substrate-binding site of p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens. Eur J Biochem (1992) 1.01
Cortical areas are revealed by distribution patterns of proteoglycan components and parvalbumin in the Mongolian gerbil and rat. Brain Res (1994) 1.01
The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog Neurobiol (1998) 1.00
Cholinergic projections from magnocellular nuclei of the basal forebrain to cortical areas in rats. Brain Res (1980) 1.00
Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation? J Chem Neuroanat (2000) 1.00
Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res (2001) 0.97
Developmental patterns of proteoglycan-containing extracellular matrix in perineuronal nets and neuropil of the postnatal rat brain. Cell Tissue Res (1997) 0.97
Aggrecan: Beyond cartilage and into the brain. Int J Biochem Cell Biol (2012) 0.95
The prognosis of mild cognitive impairment in the elderly. J Neural Transm Suppl (1998) 0.95
Postmortem changes in the phosphorylation state of tau-protein in the rat brain. Neurobiol Aging (1999) 0.95
Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease. Acta Neuropathol (1998) 0.94
Aggrecan-based extracellular matrix is an integral part of the human basal ganglia circuit. Neuroscience (2007) 0.94
Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death. Ann N Y Acad Sci (2000) 0.94
Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease. Neuroscience (2010) 0.93
Connective tissue growth factor in Alzheimer's disease. Neuroscience (2003) 0.93
Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease. Lancet (1984) 0.93
Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a. Brain Res (2000) 0.92
p75 and TrkA receptor signaling independently regulate amyloid precursor protein mRNA expression, isoform composition, and protein secretion in PC12 cells. J Neurochem (1998) 0.91
Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience (1995) 0.90
Distribution of parvalbumin-containing neurons and lectin-binding perineuronal nets in the rat basal forebrain. Brain Res (1993) 0.90
Comparison of profiles of key periodontal pathogens in periodontium and endodontium. Endod Dent Traumatol (2000) 0.89
Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience (1998) 0.89
Effect of magnocellular forebrain nuclei lesions on acetylcholine output from the cerebral cortex, electrocorticogram and behaviour. Arch Ital Biol (1982) 0.89
Morphometry of the corpus callosum in patients with questionable and mild dementia. J Neurol Neurosurg Psychiatry (2002) 0.89
Perineuronal nets in the rhesus monkey and human basal forebrain including basal ganglia. Neuroscience (2001) 0.89
Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience (1994) 0.89
Characterization of proteoglycan-containing perineuronal nets by enzymatic treatments of rat brain sections. Histochem J (1997) 0.88
Overexpression of catalytically active yeast (Saccharomyces cerevisiae) fructose-1,6-bisphosphatase in Escherichia coli. Biol Chem Hoppe Seyler (1994) 0.88
Rapid identification of oral anaerobic bacteria cultivated from subgingival biofilm by MALDI-TOF-MS. Oral Microbiol Immunol (2008) 0.88
Muscarinic acetylcholine receptors activate the acetylcholinesterase gene promoter. J Physiol Paris (1999) 0.88
Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience (1995) 0.88
Pyramidal cells ensheathed by perineuronal nets in human motor and somatosensory cortex. Neuroreport (1996) 0.87
Amyloid deposition in the nucleus basalis of Meynert complex: a topographic marker for degenerating cell clusters in Alzheimer's disease. Acta Neuropathol (1988) 0.87
Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease--a quantitative Golgi investigation. Neuroscience (1986) 0.87
Unique features of extracellular matrix in the mouse medial nucleus of trapezoid body--implications for physiological functions. Neuroscience (2012) 0.87
Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience (1999) 0.86
Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease. Neuroreport (2001) 0.86
Quantification of Microthrix parvicella in activated sludge bacterial communities by real-time PCR. Lett Appl Microbiol (2005) 0.86
Limited value of elevated erythrocyte sedimentation rate as an indicator of malignancy. Fam Pract (2002) 0.86
Analyzing the neocortical fine-structure. Med Image Anal (2003) 0.86
Isolation and characterization of an allelic cDNA for human muscle fructose-1,6-bisphosphatase. Gene (1998) 0.86
Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease. J Comp Neurol (1995) 0.86
Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain. Brain Res Mol Brain Res (2001) 0.85
Correlation between cortical theta activity and hippocampal volumes in health, mild cognitive impairment, and mild dementia. J Clin Neurophysiol (2001) 0.85
Cardiac tamponade--a rare complication in acute pancreatitis. Z Gastroenterol (1997) 0.85
Kinetic modelling of yeast phosphofructokinase. Acta Biol Med Ger (1979) 0.85
The core-shell dichotomy of nucleus accumbens in the rhesus monkey as revealed by double-immunofluorescence and morphology of cholinergic interneurons. Brain Res (2000) 0.85
Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction. Prog Brain Res (1996) 0.84
Apolipoprotein E allele 4 is not a sufficient or a necessary predictor of the development of Mild Cognitive Impairment. Eur Psychiatry (2009) 0.84
Phosphorylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol Aging (1998) 0.84
Quantitative determination of Streptococcus mutans by using competitive polymerase chain reaction. Eur J Oral Sci (1999) 0.84
Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury--II. Reactive expression of the nerve growth factor gene in astrocytes. Neuroscience (1995) 0.84
Three successful pregnancies through dietary management of fructose-1,6-bisphosphatase deficiency. J Inherit Metab Dis (2007) 0.83
The effects of cholinergic drugs and cholinergic-rich foetal neural transplants on alcohol-induced deficits in radial maze performance in rats. Behav Brain Res (1991) 0.83
The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells. Neuropathol Appl Neurobiol (2009) 0.83
In vitro demonstration of alternate stationary states in an open enzyme system containing phosphofructokinase. Arch Biochem Biophys (1980) 0.83
Electron microscopic evidence for a cholinergic innervation of GABAergic parvalbumin-immunoreactive neurons in the rat medial septum. J Neurosci Res (1998) 0.83
Deafferentation of the septo-hippocampal pathway in rats as a model of the metabolic events in Alzheimer's disease. Int J Dev Neurosci (2001) 0.83
Comparison of different techniques of quantitative PCR for determination of Streptococcus mutans counts in saliva samples. Oral Microbiol Immunol (2003) 0.83
The expression of OX40 in immunologically mediated diseases of the gastrointestinal tract (celiac disease, Crohn's disease, ulcerative colitis). Eur J Clin Invest (2000) 0.83
Activation of the hypothalamo-pituitary-adrenal axis in response to septic or non-septic diseases--implications for the euthyroid sick syndrome. Intensive Care Med (1999) 0.82
Mutation spectrum in patients with fructose-1,6-bisphosphatase deficiency. J Inherit Metab Dis (2001) 0.82
Perisynaptic aggrecan-based extracellular matrix coats in the human lateral geniculate body devoid of perineuronal nets. J Neurosci Res (2011) 0.82
Allocation of perineuronal nets and parvalbumin-, calbindin-D28k- and glutamic acid decarboxylase-immunoreactivity in the amygdala of the rhesus monkey. Brain Res (1995) 0.82
Perineuronal and perisynaptic extracellular matrix in the human spinal cord. Neuroscience (2013) 0.81
Potentiating and depressant effects of metabotropic glutamate receptor agonists on high-voltage-activated calcium currents in cultured retinal ganglion neurons from postnatal mice. Pflugers Arch (1994) 0.81
Modulation of APP processing and secretion by okadaic acid in primary guinea pig neurons. J Neural Transm (Vienna) (2000) 0.81
Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology. Neurobiol Aging (1999) 0.81
Novel mutations in patients with fructose-1,6-bisphosphatase deficiency. J Inherit Metab Dis (1999) 0.81